Literature DB >> 22260488

Childhood onset diabetes posttransplant in a girl with TCF2 mutation.

Elena Tudorache1, Anne-Laure Sellier-Leclerc, Marion Lenoir, Nadia Tubiana-Rufi, Nadia Toubiana, Albert Bensman, Christine Bellanne-Chantelot, Tim Ulinski.   

Abstract

Heterozygous mutations of TCF2 (transcription factor 2) have been associated with maturity onset diabetes of the young, renal malformations, hyperuricemia, and occasionally internal genital malformations in female. We report a female patient with bilateral renal hypodysplasia and de novo heterozygous TCF2 gene mutation. At the age of 9 yr, she developed transient ketoacidosis immediately posttransplant, temporarily requiring insulin. During glucocorticoid tapering, impaired glucose tolerance persisted and overt insulin-dependent diabetes mellitus developed 1 yr later. Pathogenic factors which might have played a role in the acceleration of diabetes were (i) switch from cyclosporine to tacrolimus, (ii) weight excess, and (iii) cytomegalovirus infection. TCF2 analysis might, therefore, be of interest in patients with congenital abnormalities of the kidney and the urinary tract in order to improve posttransplant management in terms of steroid and tacrolimus exposure.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22260488     DOI: 10.1111/j.1399-5448.2011.00842.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  4 in total

Review 1.  Pharmacogenetics of posttransplant diabetes mellitus.

Authors:  P Lancia; T Adam de Beaumais; E Jacqz-Aigrain
Journal:  Pharmacogenomics J       Date:  2017-03-28       Impact factor: 3.550

Review 2.  HNF1B-associated clinical phenotypes: the kidney and beyond.

Authors:  Detlef Bockenhauer; Graciana Jaureguiberry
Journal:  Pediatr Nephrol       Date:  2015-07-08       Impact factor: 3.714

3.  Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.

Authors:  Bilal Aoun; Stéphane Decramer; Renata Vitkevic; Hala Wannous; Flavio Bandin; Christine Azema; Patrice Callard; Isabelle Brocheriou; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2012-10-31       Impact factor: 3.714

4.  TCF2 attenuates FFA-induced damage in islet β-cells by regulating production of insulin and ROS.

Authors:  Xiaojuan Quan; Lin Zhang; Yingna Li; Chunlian Liang
Journal:  Int J Mol Sci       Date:  2014-07-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.